Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Jit

Showing results (211-220 of 407) with videos related to

Pageof 41
Sort By:
Vaccine|September 18, 2010
An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe"Mark Jit, Marie-Josée J Mangen, Hugues Melliez, et al.
Lancet (London, England)|February 15, 2021
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deploymentOlivier J Wouters, Kenneth C Shadlen, Maximilian Salcher-Konrad, et al.
BMC Medicine|March 7, 2020
Quantifying the economic cost of antibiotic resistance and the impact of related interventions: rapid methodological review, conceptual framework and recommendations for future studiesMark Jit, Dorothy Hui Lin Ng, Nantasit Luangasanatip, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 28, 2015
Quantifying Parameter and Structural Uncertainty of Dynamic Disease Transmission Models Using MCMC: An Application to Rotavirus Vaccination in England and WalesJoke Bilcke, Ruth Chapman, Christina Atchison, et al.
Vaccine|September 1, 2009
The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in EuropeMark Jit, Joke Bilcke, Marie-Josée J Mangen, et al.
Human Vaccines & Immunotherapeutics|June 5, 2013
Influenza vaccines in low and middle income countries: a systematic review of economic evaluationsJördis J Ott, Janna Klein Breteler, John S Tam, et al.
The Lancet. Public Health|March 30, 2020
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling studyKiesha Prem, Yang Liu, Timothy W Russell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 1, 2023
A Scoping Review and Taxonomy of Epidemiological-Macroeconomic Models of COVID-19Gabrielle Bonnet, Carl A B Pearson, Sergio Torres-Rueda, et al.
The Lancet Regional Health. Europe|March 13, 2024
Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccinationDavid Hodgson, Neil Wilkins, Edwin van Leeuwen, et al.
Nature Medicine|April 8, 2025
A vaccine chatbot intervention for parents to improve HPV vaccination uptake among middle school girls: a cluster randomized trialZhiyuan Hou, Zhengdong Wu, Zhiqiang Qu, et al.
Pageof 41

Showing results (211-220 of 407) with videos related to

Sort By:
Pageof 41
Vaccine|September 18, 2010
An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe"Mark Jit, Marie-Josée J Mangen, Hugues Melliez, et al.
Lancet (London, England)|February 15, 2021
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deploymentOlivier J Wouters, Kenneth C Shadlen, Maximilian Salcher-Konrad, et al.
BMC Medicine|March 7, 2020
Quantifying the economic cost of antibiotic resistance and the impact of related interventions: rapid methodological review, conceptual framework and recommendations for future studiesMark Jit, Dorothy Hui Lin Ng, Nantasit Luangasanatip, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 28, 2015
Quantifying Parameter and Structural Uncertainty of Dynamic Disease Transmission Models Using MCMC: An Application to Rotavirus Vaccination in England and WalesJoke Bilcke, Ruth Chapman, Christina Atchison, et al.
Vaccine|September 1, 2009
The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in EuropeMark Jit, Joke Bilcke, Marie-Josée J Mangen, et al.
Human Vaccines & Immunotherapeutics|June 5, 2013
Influenza vaccines in low and middle income countries: a systematic review of economic evaluationsJördis J Ott, Janna Klein Breteler, John S Tam, et al.
The Lancet. Public Health|March 30, 2020
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling studyKiesha Prem, Yang Liu, Timothy W Russell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 1, 2023
A Scoping Review and Taxonomy of Epidemiological-Macroeconomic Models of COVID-19Gabrielle Bonnet, Carl A B Pearson, Sergio Torres-Rueda, et al.
The Lancet Regional Health. Europe|March 13, 2024
Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccinationDavid Hodgson, Neil Wilkins, Edwin van Leeuwen, et al.
Nature Medicine|April 8, 2025
A vaccine chatbot intervention for parents to improve HPV vaccination uptake among middle school girls: a cluster randomized trialZhiyuan Hou, Zhengdong Wu, Zhiqiang Qu, et al.
Pageof 41